World Library  
Flag as Inappropriate
Email this Article

Cdc25

Article Id: WHEBN0003610203
Reproduction Date:

Title: Cdc25  
Author: World Heritage Encyclopedia
Language: English
Subject: Cell cycle, Cyclin B1, SH3 domain, Protein tyrosine phosphatase, CDC25
Collection: Cell Cycle, Enzymes
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Cdc25

Cdc25 is a dual-specificity phosphatase first isolated from the yeast Schizosaccharomyces pombe as a cell cycle defective mutant. As with other cell cycle proteins such as Cdc2 and Cdc4, the "cdc" in its name refers to "cell division cycle". Dual-specificity phosphatases are considered a sub-class of protein tyrosine phosphatases. By removing inhibitory phosphate residues from target Cyclin-Dependent Kinases (Cdks),[1] Cdc25 proteins control entry into and progression through various phases of the cell cycle, including mitosis and S ("Synthesis") phase.

Contents

  • Function of Cdc25 in Activating Cdk1 1
  • Structure 2
  • Evolution and Species Distribution 3
  • Knockout Models 4
  • Cdc25s in Human Disease 5
  • References 6
  • Genes 7
  • See also 8

Function of Cdc25 in Activating Cdk1

Cdc25 activates cyclin dependent kinases by removing phosphate from residues in the Cdk active site. Also, the phosphorylation of M-Cdk (a complex of Cdk1 and cyclin B) activates Cdc25. Together with Wee1, M-Cdk activation is switch-like. The switch-like behavior forces entry into mitosis to be quick and irreversible. Cdk activity can be reactivated after dephosphorylation by Cdc25. The Cdc25 enzymes Cdc25A-C are known to control the transitions from G1 to S phase and G2 to M phase.[2]

Structure

The structure of Cdc25 proteins can be divided into two main regions: the N-terminal region, which is highly divergent and contains sites for its phosphorylation and ubiquitination, which regulate the phosphatase activity; and the C-terminal region, which is highly homologous and contains the catalytic site.[3]

Evolution and Species Distribution

Cdc25 enzymes are well conserved through evolution, and have been isolated from Cdc25C. An exception is the nematode Caenorhabditis elegans, which has four distinct Cdc25 genes (Cdc-25.1 to Cdc-25.4).[8]

Knockout Models

Although the highly conserved nature of the Cdc25s implies an important role in cell physiology, Cdc25B and Cdc25C knockout mice (both single and double mutants) are viable and display no major alterations in their cell cycles,[9] suggesting some functional compensation either via other Cdk regulatory enzymes (such as Wee1 and Myt1) or from the activity of the third member of the family, Cdc25A. Hiroaki Kiyokawa's laboratory has shown that Cdc25A knockout mice are not viable.

Cdc25s in Human Disease

The Cdc25s, and in particular Cdc25A and Cdc25B, are proto-oncogenes in humans and have been shown to be overexpressed in a number of cancers.[10] The central role of Cdc25s in the cell cycle has garnered them considerable attention from the pharmaceutical industry as potential targets for novel chemotherapeutic (anti-cancer) agents.[3] To date, no clinically viable compounds targeting these enzymes have been described.

A large number of potent small-molecule Cdc25 Inhibitors have been identified that bind to the active site and belong to various chemical classes including natural products, lipophilic acids, quinonoids, electrophilies, sulfonylated aminothiazoles and phosphate bioisosteres.[3] Although some progress has been made in developing potent and selective inhibitors for Cdc25 family of proteins, there is scope for development of novel therapeutic strategies to target them. A new class of peptide-derived inhibitors, based on sequence homology with the protein substrate, can be developed. It is challenging to use these compounds as drugs due to their lack of suitable ADME properties.[3]

References

  1. ^ Strausfeld U, Labbé JC, Fesquet D; et al. (May 1991). "Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein". Nature 351 (6323): 242–5.  
  2. ^ Morgan, David. The Cell Cycle: Principles of Control. London: New Science Press, 2007. 96-98, 34-35. Print.
  3. ^ a b c d Presentation on CDC25 PHOSPHATASES: A Potential Target for Novel Anticancer Agents
  4. ^ Sadhu K, Reed SI, Richardson H, Russell P (July 1990). "Human homolog of fission yeast cdc25 mitotic inducer is expressed predominantly in G2". Proc. Natl. Acad. Sci. U.S.A. 87 (13): 5139–43.  
  5. ^ Landrieu I, da Costa M, De Veylder L; et al. (September 2004). "A small CDC25 dual-specificity tyrosine-phosphatase isoform in Arabidopsis thaliana". Proc. Natl. Acad. Sci. U.S.A. 101 (36): 13380–5.  
  6. ^ Edgar BA, O'Farrell PH (April 1989). "Genetic Control of Cell Division Patterns in the Drosophila Embryo". Cell 57 (1): 177–87.  
  7. ^ Alphey L, Jimenez J, White-Cooper H, Dawson I, Nurse P, Glover DM (June 1992). "twine, a cdc25 homolog that functions in the male and female germline of Drosophila". Cell 69 (6): 977–88.  
  8. ^ Ashcroft NR, Kosinski ME, Wickramasinghe D, Donovan PJ, Golden A (July 1998). "The four cdc25 genes from the nematode Caenorhabditis elegans". Gene 214 (1–2): 59–66.  
  9. ^ Ferguson AM, White LS, Donovan PJ, Piwnica-Worms H (April 2005). "Normal Cell Cycle and Checkpoint Responses in Mice and Cells Lacking Cdc25B and Cdc25C Protein Phosphatases". Mol. Cell. Biol. 25 (7): 2853–60.  
  10. ^ Kristjánsdóttir K, Rudolph J (August 2004). "Cdc25 phosphatases and cancer". Chem. Biol. 11 (8): 1043–51.  

Genes

  • CDC25A
    • Human cDc25A at PDB
  • CDC25B
  • CDC25C

See also

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.